Literature DB >> 24602285

Pregnancy complications in HIV-positive women: 11-year data from the Frankfurt HIV Cohort.

A Reitter1, A U Stücker, R Linde, C Königs, G Knecht, E Herrmann, R Schlößer, F Louwen, A Haberl.   

Abstract

OBJECTIVES: The aim of the study was to assess pregnancy complications in HIV-positive women and changes in the rates of such complications over 11 years in the Frankfurt HIV Cohort.
METHODS: There were 330 pregnancies in HIV-positive women between 1 January 2002 and 31 December 2012. The rate of pregnancy-related complications, such as gestational diabetes mellitus (GDM), pre-eclampsia and preterm delivery, the mode of delivery and obstetric history were analysed. Maternal and neonatal morbidity/mortality as well as HIV mother-to-child transmission (MTCT) were evaluated.
RESULTS: In our cohort, GDM was diagnosed in 38 of 330 women (11.4%). Five women (1.5%) developed pre-eclamspia or hypertension. In 16 women (4.8%), premature rupture of membranes (PROM) occurred and 46 women (13.7%) were admitted with preterm contractions. The preterm delivery rate was 36.5% (n = 122), and 26.9% of deliveries (n = 90) were between 34+0 and 36+6 weeks of gestation. Over the observation period, the percentage of women with undetectable HIV viral load (VL) increased significantly (P < 0.001), from 26.1% to 75%, leading to obstetric changes, including an increase in the rate of vaginal deliveries (P < 0.001), from no vaginal births to 50%. The preterm delivery rate decreased significantly (P < 0.001), from 79.2% to 8.3%. There were no significant changes in the rate of GDM, pre-eclampsia, PROM or preterm contractions.
CONCLUSIONS: In the 11 years of our analysis, there was a significant reduction in the rate of preterm deliveries and an increase in the vaginal delivery rate, possibly reflecting changes in treatment policies in the same period and the availability of more effective antiretroviral therapy options. The rates of complications such as GDM, pre-eclampsia, preterm contractions, PROM and postnatal complications were stable over the 11 years, but were still increased compared with the general population.
© 2014 British HIV Association.

Entities:  

Keywords:  HIV; gestational diabetes mellitus (GDM); high-risk pregnancy; highly active antiretroviral therapy (HAART); mother-to-child transmission (MTCT); preterm delivery

Mesh:

Substances:

Year:  2014        PMID: 24602285     DOI: 10.1111/hiv.12142

Source DB:  PubMed          Journal:  HIV Med        ISSN: 1464-2662            Impact factor:   3.180


  15 in total

Review 1.  Is there a connection between gestational diabetes mellitus, human immunodeficiency virus infection, and tuberculosis?

Authors:  M Alexander; A Gupta; J S Mathad
Journal:  Int J Tuberc Lung Dis       Date:  2019-01-01       Impact factor: 2.373

2.  Physiologically based pharmacokinetic modelling prediction of the effects of dose adjustment in drug-drug interactions between levonorgestrel contraceptive implants and efavirenz-based ART.

Authors:  Owain Roberts; Rajith K R Rajoli; David J Back; Andrew Owen; Kristin M Darin; Courtney V Fletcher; Mohammed Lamorde; Kimberly K Scarsi; Marco Siccardi
Journal:  J Antimicrob Chemother       Date:  2018-04-01       Impact factor: 5.790

Review 3.  Surveillance monitoring for safety of in utero antiretroviral therapy exposures: current strategies and challenges.

Authors:  Rebecca M Zash; Paige L Williams; Jeanne Sibiude; Hermione Lyall; Fatima Kakkar
Journal:  Expert Opin Drug Saf       Date:  2016-09-06       Impact factor: 4.250

4.  Contraception values and preferences of people living with HIV: A systematic review.

Authors:  Haneefa T Saleem; Joseph G Rosen; Caitlin Quinn; Avani Duggaraju; Caitlin E Kennedy
Journal:  Contraception       Date:  2021-11-05       Impact factor: 3.051

5.  Full Viral Suppression, Low-Level Viremia, and Quantifiable Plasma HIV-RNA at the End of Pregnancy in HIV-Infected Women on Antiretroviral Treatment.

Authors:  Silvia Baroncelli; Maria F Pirillo; Enrica Tamburrini; Giovanni Guaraldi; Carmela Pinnetti; Anna Degli Antoni; Clementina M Galluzzo; Chiara Stentarelli; Roberta Amici; Marco Floridia
Journal:  AIDS Res Hum Retroviruses       Date:  2015-04-08       Impact factor: 2.205

Review 6.  Gonadal function and reproductive health in women with human immunodeficiency virus infection.

Authors:  Swaytha Yalamanchi; Adrian Dobs; Ruth M Greenblatt
Journal:  Endocrinol Metab Clin North Am       Date:  2014-09       Impact factor: 4.741

7.  Profile of Chronic Comorbid Conditions and Obstetrical Complications Among Pregnant Women With Human Immunodeficiency Virus and Receiving Antiretroviral Therapy in the United States.

Authors:  Kartik K Venkatesh; Leavitt Morrison; Ruth E Tuomala; Alice Stek; Jennifer S Read; David E Shapiro; Elizabeth G Livingston
Journal:  Clin Infect Dis       Date:  2021-09-15       Impact factor: 9.079

8.  Low Bioactive Vitamin D Is Associated with Pregnancy-Induced Hypertension in a Cohort of Pregnant HIV-Infected Women Sampled Over a 23-Year Period.

Authors:  Kristi R Van Winden; Allison Bearden; Naoko Kono; Toni Frederick; Eva Operskalski; Alice Stek; Raj Pandian; Lorayne Barton; Andrea Kovacs
Journal:  Am J Perinatol       Date:  2019-07-31       Impact factor: 3.079

9.  Gestational diabetes in women living with HIV in Botswana: lower rates with dolutegravir- than with efavirenz-based antiretroviral therapy.

Authors:  K N Mmasa; K Powis; S Sun; J Makhema; M Mmalane; S Kgole; G Masasa; S Moyo; M Gerschenson; T Mohammed; J Legbedze; E J Abrams; I J Kurland; M E Geffner; J Jao
Journal:  HIV Med       Date:  2021-05-18       Impact factor: 3.094

10.  Comprehensive nationwide analysis of mother-to-child HIV transmission in Finland from 1983 to 2013.

Authors:  I Aho; P Kivelä; M Kaijomaa; H-M Surcel; M Ristola; O Heikinheimo; J Sutinen
Journal:  Epidemiol Infect       Date:  2018-05-15       Impact factor: 4.434

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.